News & Events

February 21, 2021

Feds Give Direction on Reopening Schools for Students with Disabilities

The CDC and Department of Education Want In-Person Learning But with Precautions Two separate documents issued earlier this month from the federal government outlined plans to safely reopen schools for in-person learning. These guidelines include details for students with disabilities. The Centers for Disease Control and Prevention (CDC) released an operational strategy document for schools […]

February 21, 2021

Urge Congress Members to Include Home and Community-Based Services in Next COVID Relief Bill

Additional Funding Critical to Keep Individuals with Disabilities Safe at Home as Pandemic Continues A new COVID relief bill is currently making its way through the halls of Congress. Since the beginning of the pandemic, the disability community has requested dedicated funding towards home and community-based services (HCBS) to be included in COVID relief legislation […]

February 15, 2021

Chronic Viral Encephalopathy Mistaken for Schizophrenia

16-Year-Old Boy Lost Psychiatric Symptoms After Antiviral Treatment A recent case report published in the British Medical Journal features the account of a teenage boy who had been experiencing symptoms of paranoid ideation, anxiety, fear and hallucinations for a period of three months. A psychiatric hospital diagnosed the teen with schizophrenia and prescribed the antipsychotic […]

February 15, 2021

Decreased Phenol Sulfotransferase Linked to Common Autism Biomarker

Hyperserotonemia Has Been Associated with ASD for Decades for Unknown Reasons Until Now Hyperserotonemia is the state of increased whole blood serotonin within the body. The condition is the most replicated biochemical abnormality associated with autism spectrum disorders (ASD). The etiology of this biomarker was poorly understood until now. A new French study published in […]

February 15, 2021

Another Suramin Study Shows Promise for Treating Core Symptoms of Autism

Research Involved an Intravenous Form of Suramin Called PAX-101 Exciting news surrounding a potential autism medication was delivered from New Jersey last week. PaxMedica, a biopharmaceutical company, announced impressive results from their phase 2 dose-ranging clinical trial investigating their product PAX-101 (IV suramin) as a potential therapeutic to alleviate core symptoms of autism spectrum disorder […]

February 15, 2021

Most Medical Doctors View the Lives of Individuals with Disabilities as Subpar

Lead Author of New Study Calls Findings, “Very Disturbing”  Approximately 12% of  Americans have at least one disability. Growing evidence shows that individuals living with disabilities experience healthcare disparities compared to the general population. A new study published in the journal Health Affairs was the first of its kind to examine doctors’ attitudes on treating […]

Show Buttons
Hide Buttons